Bridgeway Capital Management’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-6,076
| Closed | -$595K | – | 1543 |
|
|
2016
Q4 | $595K | Hold |
6,076
| – | – | 0.01% | 1017 |
|
|
2016
Q3 | $604K | Sell |
6,076
-720
| -11% | -$71.6K | 0.01% | 1006 |
|
|
2016
Q2 | $833K | Buy |
6,796
+2,725
| +67% | +$334K | 0.01% | 850 |
|
|
2016
Q1 | $521K | Buy |
4,071
+2,071
| +104% | +$265K | 0.01% | 1030 |
|
|
2015
Q4 | $92K | Hold |
2,000
| – | – | ﹤0.01% | 1380 |
|
|
2015
Q3 | $194K | Hold |
2,000
| – | – | ﹤0.01% | 1318 |
|
|
2015
Q2 | $274K | Hold |
2,000
| – | – | 0.01% | 1276 |
|
|
2015
Q1 | $356K | Hold |
2,000
| – | – | 0.01% | 1208 |
|
|
2014
Q4 | $400K | Buy |
+2,000
| New | +$400K | 0.01% | 1144 |
|